SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
GM-Backed Momenta's $9 Billion IPO Gets a Reality Check As Chinese Self-Driving Startup's Shares Slip in Hong Kong Debut...
Wells Fargo Maintains Overweight on Merck & Co, Raises Price Target to $150...
Chamath Palihapitiya Explains Why He Would Pick SPCX Over OpenAI, Anthropic...
Reported Earlier, 'Obamacare Insurers Seek Big Rate Hikes, Again' - WSJ Exclusive...
Keefe, Bruyette & Woods Downgrades Travelers Companies to Market Perform, Raises Price Target to $356...
Barclays Maintains Equal-Weight on Verizon Communications, Lowers Price Target to $45...
Shifting Tides For Chinese Brands: Transsion Stumbles Outside Africa And Cafe de Coral Turns Around...
What's Going on With Chevron Stock Wednesday?...
Obamacare Premiums Could Jump 14% in 2027 As Insurers Warn Rising Medical Costs are Driving Rates Higher...
Johnson & Johnson Receives FDA Approval For Its Dual Energy THERMOCOOL SMARTTOUCH SF Catheter Platform...
How To Earn $500 A Month From JPMorgan Stock Ahead Of Q2 Earnings...
Why Is Intel Stock Falling Wednesday?...
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday...
Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday...
Nvidia, Microsoft, ServiceNow And More On CNBC’s ‘Final Trades’...
Barclays Initiates Coverage On Visa with Overweight Rating, Announces Price Target of $420...
Chevron And ZL Chemicals Announce Technology Licensing Agreement Chemical Surfactant Technology; ZL Plans To Offer Products And Services Utilizing Lic...
'JPMorgan Plans to Target Small-Company Deals as Part of M&A Push' - Wall Street Journal Exclusive...
Samsung Now Makes More Money Than Nvidia — And Goldman Says the Stock Is Still Dirt Cheap...
Forget The Airlines, The Hidden Monopoly Is Pocketing Your Higher Airfare...